Zhejiang Yatai Pharmaceutical (002370.SZ) has released a profit forecast, estimating a net profit of 25-37 million yuan for the year 2024, turning from a loss to a profit compared to the previous year.
AP Group (002370.SZ) released its forecast for the performance in 2024, with an expected full-year net profit attributable to shareholders of the listed company...
Zhejiang Yatai Pharmaceutical (002370.SZ) has released its performance forecast for the year 2024, expecting a net profit attributable to shareholders of the listed company of 25 to 37 million yuan for the full year, turning losses into profits compared to the previous year.
Related Articles
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
New Stock Outlook | With the support of more than ten state-owned shareholders, can the merger and acquisition growth story of Tiandi HeXing earn market approval?
Guosen: The final mindset of asset trend convergence.
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
